Royalty expense
Boston Scientific Royalty expense increased by 100.0% to $12.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.3%, from $14.00M to $12.00M. Over 4 years (FY 2021 to FY 2025), Royalty expense shows relatively stable performance with a -1.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase reflects higher reliance on licensed technology, while a decrease may indicate the expiration of licenses or a shift toward internal R&D.
Detailed definition
Represents payments made to third parties for the use of intellectual property, patents, or proprietary technologies. Th...
Peer comparison
Common in medical device and pharma sectors; varies based on the company's reliance on external versus internal IP.
operating_expenses_royalty_expenseHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.00M | $14.00M | $11.00M | $12.00M | $11.00M | $11.00M | $13.00M | $11.00M | $12.00M | $11.00M | $11.00M | $10.00M | $9.00M | $5.00M | $9.00M | $14.00M | $14.00M | $12.00M | $6.00M | $12.00M |
| QoQ Change | — | +16.7% | -21.4% | +9.1% | -8.3% | +0.0% | +18.2% | -15.4% | +9.1% | -8.3% | +0.0% | -9.1% | -10.0% | -44.4% | +80.0% | +55.6% | +0.0% | -14.3% | -50.0% | +100.0% |
| YoY Change | — | — | — | — | -8.3% | -21.4% | +18.2% | -8.3% | +9.1% | +0.0% | -15.4% | -9.1% | -25.0% | -54.5% | -18.2% | +40.0% | +55.6% | +140.0% | -33.3% | -14.3% |
Royalty expense at Other Companies
Frequently Asked Questions
- What is Boston Scientific's royalty expense?
- Boston Scientific (BSX) reported royalty expense of $12.00M in Q1 2026.
- How has Boston Scientific's royalty expense changed year-over-year?
- Boston Scientific's royalty expense decreased by 14.3% year-over-year, from $14.00M to $12.00M.
- What is the long-term trend for Boston Scientific's royalty expense?
- Over 4 years (2021 to 2025), Boston Scientific's royalty expense has grown at a -1.6% compound annual growth rate (CAGR), from $49.00M to $46.00M.
- What does royalty expense mean?
- Fees paid to others for the right to use their patented technology or intellectual property.